Immatics NV IMTXW:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 09/24/21 EDT
4.04quote price arrow down-0.30 (-6.91%)
Volume
5,784
52 week range
1.67 - 6.64
Loading...
  • Open4.25
  • Day High4.28
  • Day Low4.04
  • Prev Close4.34
  • 52 Week High6.64
  • 52 Week High Date03/17/21
  • 52 Week Low1.67
  • 52 Week Low Date03/05/21

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open4.25
  • Day High4.28
  • Day Low4.04
  • Prev Close4.34
  • 52 Week High6.64
  • 52 Week High Date03/17/21
  • 52 Week Low1.67
  • 52 Week Low Date03/05/21
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Immatics NV

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Immatics NV is a clinical-stage biopharmaceutical company that is based in the Netherlands. The Company is focused on the discovery and development of T-Cell eceptors with the goal of enabling a robust and specific T-Cell response against these targets. The Company develops targeted immunotherapies with an emphasis on treating solid tumors through two distinct therapeutic modalities: Adoptive Cell Therapies (ACT) and antibody-like TCR Bispecifics (TCER). Its wholly owned...
Address
Paul Ehrlich-Strasse 15
Tuebingen
72076
Germany